Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Opinion in Virology|April 27, 2021
Future considerations for the mRNA-lipid nanoparticle vaccine platformBotond Z Igyártó, Sonya Jacobsen, Sonia Ndeupen
Biorxiv : the Preprint Server for Biology|March 10, 2021
The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatorySonia Ndeupen, Zhen Qin, Sonya Jacobsen, et al.
Iscience|November 29, 2021
The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatorySonia Ndeupen, Zhen Qin, Sonya Jacobsen, et al.
Plos Pathogens|January 24, 2022
Langerhans cells and cDC1s play redundant roles in mRNA-LNP induced protective anti-influenza and anti-SARS-CoV-2 immune responsesSonia Ndeupen, Aurélie Bouteau, Christopher Herbst, et al.
Cell Reports|August 3, 2025
Identification of the seven critical residues that control ZIKV-DENV cross-reactivity to engineer a non-cross-reactive ZIKV vaccineAriadna Grinyo-Escuer, Srikar Reddy, Agnes L Chenine, et al.
Pageof 1